Institutional Investors: Conversion and Why Timing Matters30 Jul 2025 23:23
There seems to be some confusion around whether institutional investors will rush to convert their £10m CLN into shares asap, simply because they can. It’s worth thinking through this a little more strategically.
The CLN gives them the OPTION to convert at a 20% discount to the VWAP, not the obligation. These aren’t retail punters chasing a quick win. These are institutions with longer horizons and risk models that tend to favour upside scenarios. If HE1 delivers on its potential, the value of those convertible shares increases significantly the longer they hold off.
Why would they convert at a ~0.7p VWAP, when the company has already signposted high-impact news ahead and an asset with tier-1 potential? That would be financially inefficient.
It’s also worth remembering: aggressive early conversion would risk spooking the market, depressing the share price, and reducing their own return. That’s NOT good business.
So yes, the mechanism exists. But smart capital doesn’t play its hand early unless there’s a reason. As it stands, there’s more INCENTIVE TO WAIT than convert, and that should give some comfort to holders worried about near-term dilution.
This isn’t just about what’s possible, it’s about what makes strategic sense.
After all, you don’t fire your best shot before the target even moves. 🎯📈